US Stock MarketDetailed Quotes
FLGT Fulgent Genetics
- 20.090
- -0.630-3.04%
Close Apr 17 16:00 ET
600.70MMarket Cap-3568P/E (TTM)
20.880High20.070Low221.62KVolume20.810Open20.720Pre Close4.52MTurnover1.11%Turnover RatioLossP/E (Static)29.90MShares44.09052wk High0.53P/B401.08MFloat Cap20.07052wk Low--Dividend TTM19.96MShs Float189.890Historical High--Div YieldTTM3.91%Amplitude2.725Historical Low20.387Avg Price1Lot Size
About Fulgent Genetics Company
Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded by Ming Hsieh on May 13, 2016 and is headquartered in El Monte, CA.
Company Profile
SymbolFLGT
Company NameFulgent Genetics
Listing DateSep 29, 2016
Issue Price9.00
Founded2016
CEOMr. Ming Hsieh
MarketNASDAQ
Employees1184
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address4399 Santa Anita Avenue
CityEl Monte
ProvinceCalifornia
CountryUnited States of America
Zip Code91731
Phone1-626-350-0537
Company Executives
- Name
- Position
- Salary
- Ming Hsieh
- Chairman of the Board and Chief Executive Officer
- 5.31M
- Hanlin Gao, M.D.
- Chief Scientific Officer
- 1.49M
- Paul Kim
- Chief Financial Officer and Principal Accounting Officer
- 1.78M
- Jian Xie
- President and Chief Operating Officer
- 1.79M
- Linda Marsh
- Independent Director
- 270.50K
- Michael Nohaile, PhD
- Independent Director
- 268.50K
- Regina E. Groves
- Independent Director
- 625.60K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg